First Interstate Bank Has $376,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

First Interstate Bank cut its position in CVS Health Co. (NYSE:CVS) by 19.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,764 shares of the pharmacy operator’s stock after selling 1,160 shares during the period. First Interstate Bank’s holdings in CVS Health were worth $376,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Cantor Fitzgerald Investment Advisor L.P increased its position in shares of CVS Health by 92.9% during the first quarter. Cantor Fitzgerald Investment Advisor L.P now owns 377,875 shares of the pharmacy operator’s stock worth $38,245,000 after acquiring an additional 181,966 shares in the last quarter. United Bank increased its position in shares of CVS Health by 7.2% during the first quarter. United Bank now owns 18,658 shares of the pharmacy operator’s stock worth $1,888,000 after acquiring an additional 1,260 shares in the last quarter. Loomis Sayles & Co. L P increased its position in shares of CVS Health by 4,063.8% during the first quarter. Loomis Sayles & Co. L P now owns 12,075 shares of the pharmacy operator’s stock worth $1,222,000 after acquiring an additional 11,785 shares in the last quarter. Zions Bancorporation N.A. increased its position in shares of CVS Health by 116.9% during the first quarter. Zions Bancorporation N.A. now owns 2,572 shares of the pharmacy operator’s stock worth $260,000 after acquiring an additional 1,386 shares in the last quarter. Finally, Ergoteles LLC bought a new stake in shares of CVS Health during the first quarter worth $1,551,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of NYSE CVS traded up $0.07 during mid-day trading on Tuesday, reaching $69.03. 9,591,628 shares of the company were exchanged, compared to its average volume of 10,944,345. The company’s 50-day simple moving average is $75.78 and its 200-day simple moving average is $73.78. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $87.01 billion, a P/E ratio of 10.86, a P/E/G ratio of 0.91 and a beta of 0.52. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. CVS Health’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.99 EPS. As a group, research analysts predict that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.85%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is 41.18%.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.24% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of analyst reports. SVB Leerink initiated coverage on shares of CVS Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price for the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research report on Wednesday, April 10th. Barclays initiated coverage on shares of CVS Health in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 target price for the company. HSBC initiated coverage on shares of CVS Health in a research report on Friday, December 22nd. They issued a “buy” rating and a $94.00 target price for the company. Finally, Royal Bank of Canada decreased their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research report on Thursday, February 8th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $89.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.